Objectives: To improve the level of recognition, diagnostic and treatment of IgD multiple myeloma (MM). METHODS: Four IgD MM patients were studied retrospectively on clinical characteristics, and related literatures were reviewed. RESULTS: The median incidence of age was 60.75 years. Third of the fourth were lambda-light chain(75%), only one was IgD-kappa light chain type(25%). All the patients had stage IIIB. The presenting features included bone pain, anemia, wasting, renal inadequacy, massive pleural effusion etc. β2-MG、LDH and CRP all elevated in some degree. The median survival time was 31 months. CONCLUSION: IgD MM is rear and has a poor prognosis. We should pay attention during our daily work. |